Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 209,921,012 papers from all fields of science
Search
Sign In
Create Free Account
THERATOPE
Known as:
THERATOPE STn-KLH vaccine
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
cyclophosphamide/THERATOPE STn-KLH vaccine
sialyl-Tn antigen-keyhole-limpet hemocyanin conjugate
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2004
Review
2004
Vaccination with Theratope® (STn-KLH) as treatment for breast cancer
L. Holmberg
,
B. Sandmaier
Expert Review of Vaccines
2004
Corpus ID: 46631997
Cancer vaccines have demonstrated that they can stimulate antibody and cell-mediated immune responses against tumor-associated…
Expand
Review
2003
Review
2003
Clinical development of the STn-KLH vaccine (Theratope).
N. Ibrahim
,
J. Murray
Clinical Breast Cancer
2003
Corpus ID: 22048174
The development of active specific immunotherapy depends on the identification of altered cancer cell-specific molecules or…
Expand
Review
2003
Review
2003
Rationale for the clinical development of STn-KLH (Theratope) and anti-MUC-1 vaccines in breast cancer.
D. Miles
,
Kostas Papazisis
Clinical Breast Cancer
2003
Corpus ID: 35034298
Mucin-1 (MUC-1) is a high-molecular-weight glycoprotein rich in serine and threonine residues that are O-glycosylated. Expression…
Expand
2003
2003
The role of cancer vaccines following autologous stem cell rescue in breast and ovarian cancer patients: experience with the STn-KLH vaccine (Theratope).
L. Holmberg
,
D. V. Oparin
,
T. Gooley
,
B. Sandmaier
Clinical Breast Cancer
2003
Corpus ID: 30255855
The success of high-dose chemotherapy followed by autologous stem-cell rescue as treatment for breast and ovarian cancer is…
Expand
Review
2003
Review
2003
Cancer Vaccine THERATOPE® — Biomira
A. Editorial
Drugs in R&D
2003
Corpus ID: 8217897
Biomira is developing a therapeutic cancer vaccine [THERATOPE®] for treatment of breast and other cancers.1 THERATOPE® consists…
Expand
Review
2001
Review
2001
Theratope® vaccine (STn-KLH)
L. Holmberg
,
B. Sandmaier
Expert Opinion on Biological Therapy
2001
Corpus ID: 451667
Active specific immunotherapy (ASI) is a promising approach to treating cancer. Numerous studies in the laboratory have…
Expand
Highly Cited
2000
Highly Cited
2000
Clinical outcome of breast and ovarian cancer patients treated with high-dose chemotherapy, autologous stem cell rescue and THERATOPE® STn-KLH cancer vaccine
L. Holmberg
,
D. Oparin
,
+6 authors
B. Sandmaier
Bone Marrow Transplantation
2000
Corpus ID: 23811292
The purpose of this study was to evaluate the toxicity and potential efficacy of administering the THERATOPE® STn-KLH cancer…
Expand
Review
2000
Review
2000
Technology evaluation: Theratope, Biomira Inc.
M. Morse
Current opinion in molecular therapeutics (Print)
2000
Corpus ID: 39168794
Active specific immunotherapy, the use of 'vaccines' to stimulate therapeutic tumor antigen-specific immune responses, holds…
Expand
Highly Cited
1996
Highly Cited
1996
Enhancing the effect of THERATOPE STn-KLH cancer vaccine in patients with metastatic breast cancer by pretreatment with low-dose intravenous cyclophosphamide.
G. Maclean
,
D. Miles
,
R. Rubens
,
M. Reddish
,
B. Longenecker
Journal of Immunotherapy with Emphasis on Tumor…
1996
Corpus ID: 25519606
THERATOPE (Biomira Inc., Edmonton, AB, Canada) STn-KLH cancer vaccine induces strong antibody titers against both the synthetic…
Expand
Highly Cited
1996
Highly Cited
1996
Pre-immunotherapy serum CA27.29 (MUC-1) mucin level and CD69+ lymphocytes correlate with effects of Theratope® sialyl-Tn-KLH cancer vaccine in active specific immunotherapy
M. Reddish
,
G. Maclean
,
S. Poppema
,
A. Berg
,
B. Longenecker
Cancer Immunology and Immunotherapy
1996
Corpus ID: 20986044
Abstract Patients with metastatic breast, colorectal or ovarian cancers received active specific immunotherapy (ASI) with…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE